Bharat Biotech

Brazil To Suspend USD 324 Million Covaxin Vaccine Deal Over Accusations Of Irregularities

Brazil Govt Faces Probe For Choosing Bharat Biotech's Covaxin Deal Over 'Cheaper' Pfizer Vaccine | All About Controversy

Covaxin Phase 3 Trial Data Shows 77.8% Efficacy, Gets Approval From DCGI's Expert Panel

Coronavirus HIGHLIGHTS: Bharat Biotech Submitted COVAXIN's Phase 3 Clinical Trial Data To DCGI, Say Govt Sources

Covaxin Supplies At Rs 150/Dose ‘Non-Competitive Price, Not Sustainable’: Bharat Biotech Defends Higher Price

No Emergency Use Approval For Covaxin In US; Phase 3 Trial Data Expected To Be Published In 7-8 Days, Says Dr VK Paul

Covid Vaccine Prices To Be Revised, Centre In Talks With Serum Institute & Bharat Biotech: Sources

Early Covaxin Study Shows Protections Against Beta & Delta Variants Of Covid-19

Covishield Elicits Better Antibody Response Than Covaxin: Study

AIIMS Delhi To Begin Covaxin Trials On Children Today Amid Third Wave Scare

Biological E’s Corbevax At Rs 250/Dose May Be Cheapest Covid-19 Vaccine In India

'More Info Required': WHO To Bharat Biotech As It Submits ‘90% Documents’ For Emergency Use Listing Of Covaxin